Search
-
Cancer Straight Talk Podcast
A recent clinical trial for rectal cancer headed up by MSK has grabbed the attention of the world. Like a miracle, in a subset of patients with the right genetic makeup, an IV infusion of an immunotherapy caused a complete remission in every single patient. The doctors were shocked.
… Breakthrough Rectal Cancer Drug Trial: What It Means For You (Spanish) Breakthrough Rectal Cancer Drug Trial: What It Means For You (Spanish) Escúchelo en Español Leif Brostrom Thursday, December 8, 2022 - 11:41 AM Thu, 12/08/2022 - 11:41 a.m.
-
The most common sign of bladder cancer is blood in the urine. Learn more about what to look for and other symptoms that may be present.
… Blood in the urine (hematuria) is the most common sign of bladder cancer. This is a warning sign of bladder cancer for all genders, and for non-muscle invasive (NMIBC) and invasive bladder cancer. Muscle invasive bladder cancer means the cancer is in the muscle of the bladder. Most bladder cancer is
-
The Charles Sawyers Lab
… Job Title Laboratory Manager Degree PhD Email [email protected] Lab Fax 646-888-2595 Lab Phone 646-888-2163
-
-
-
Radiation OncologistMinsi Zhang is a radiation oncologist who uses ionizing radiation to treat various types of cancers.
… Radiation Oncologist Job Title Assistant Attending Radiation Oncologist I am a radiation oncologist who uses ionizing radiation to treat various types of cancers. A close family member’s diagnosis of cancer when I was in medical school cemented my interest in the field of oncology. I was specifically
-
Radiation OncologistMinsi Zhangy es una oncóloga de radioterapia que utiliza radiación ionizante para tratar varios tipos de cáncer.
… Radiation Oncologist Job Title Instructora Soy una oncóloga de radioterapia que utiliza radiación ionizante para tratar varios tipos de cáncer. El diagnóstico de cáncer de un miembro cercano de mi familia cuando estaba en la facultad de medicina consolidó mi interés en el campo de la oncología. Me atrajo
-
The Maria Jasin Lab
… Tea will be served at 12:45 p.m. , immediately preceding the seminar. Audience This seminar is open to the research community. Location Memorial Sloan Kettering Cancer Center Zuckerman Research Center 417 East 68th Street Room ZRC-Auditorium New York, NY 10065 Speaker(s) Alberto Ciccia, PhD Associate
-
-
Clinical Trial
… Full Title A Global Pivotal Study in Participants with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in those with PD-L1 expression >=50% or LY3537982 and Pembrolizumab, Pemetrexed